Attached files

file filename
EX-99.3 - EXHIBIT 99.3 - CVD EQUIPMENT CORPex_102931.htm
EX-99.1 - EXHIBIT 99.1 - CVD EQUIPMENT CORPex_102897.htm
8-K/A - FORM 8-K/A - CVD EQUIPMENT CORPcvv20180111_8ka.htm

Exhibit 99.2

 

Mesoscribe Technologies, Inc.

Balance Sheet

As of June 30, 2017

 

   

2017

 

ASSETS

       

Current Assets

       

Cash and cash equivalents

  $ 303,684  

Accounts receivable, net

    70,689  

Inventory

    95,579  

Accrued revenue

    94,000  

Deferred tax asset

    231,660  

Prepaid corporate taxes

    82,836  

Prepaid expenses

    30,169  

Total Current Assets

    908,617  
         
         

Property and equipment, net

    92,367  
         

Goodwill

    100,000  

Patents, net

    28,117  

Security deposit

    36,072  

Total Assets

  $ 1,165,173  
         
         

LIABILITIES AND STOCKHOLDERS’ EQUITY

       

Current Liabilities

       

Accounts payable

  $ 3,010  

Accrued expenses

    109,438  

Deferred income taxes

    4,126  

Total Current Liabilities

    116,574  
         

Shareholder loan

    20,743  

Total Liabilities

    137,317  
         

Stockholders’ Equity:

       

Common stock - $0.01 par value – 20,000,000 shares authorized at June 30, 2017 and September 30, 2016: issued and outstanding 10,500,000 at

       

June 30, 2017 and at September 30, 2016

    10,500  

Additional paid-in capital

    16,109  

Retained earnings

    1,001,247  

Total Stockholders’ Equity

    1,027,856  
         

Total Liabilities and Stockholders’ Equity

  $ 1,165,173  

 

 

 

 

Mesoscribe Technologies, Inc.

Statement of Operations and Retained Earnings

For the Three and Nine Months Ended June 30, 2017

 

   

Three months

   

Nine months

 
   

Ended June 30, 2017

   

Ended June 30, 2017

 
                 

Revenue

  $ 181,061     $ 640,252  
                 

Cost of revenue

    73,324       276,476  
                 

Gross profit

    107,737       363,775  
                 

General and Administrative expenses

    213,184       615,491  
                 

Total General and Administrative Expenses

    213,184       615,491  
                 

Operating (loss)

    (105,447 )     (251,716 )
                 

Other income (expense):

               

Interest income

    45       145  

Deferred tax income

    42,015       100,709  

Penalties

    (70 )     (147 )

Total other (expense)/income net

    41,989       100,706  
                 

(Loss) before income tax expense

    (63,459 )     (151,010 )
                 

Income tax expense

    ---       1,100  
                 

Net (loss)

  $ (63,459 )   $ (152,110 )
                 

Retained Earnings, Beginning of year

    1,064,706       1,153,357  
                 

Retained Earnings, End of year

    1,001,247       1,001,247  

 

 

 

 

Mesoscribe Technologies, Inc.

Statements of Cash Flows

For the Three and Nine Months ended June 30, 2017

 

   

Three Months

   

Nine Months

 
   

Ended June 30,

   

Ended June 30,

 
   

2017

   

2017

 

Cash flows from operating activities:

               

Net (loss)

  $ (63,459 )   $ (152,110 )

Adjustments to reconcile net (loss)/income to net cash used in operating activities

               

Depreciation and amortization

    7,784       23,352  

Deferred income tax benefit

    (39,437 )     (93,143 )

Increase/(decrease) in operating assets

               

Accounts receivable

    37,984       167,411  

Inventory, net

    (512 )     (2,145 )

Accrued revenue

    (94,000 )     (94,000 )

Other current assets

    (10,367 )     (18,708 )

Increase/(decrease) in operating liabilities

               

Accounts payable

    72       (986 )

Accrued expenses

    5,050       (16,709 )

Accrued litigation settlement

    ---          

Deferred revenue

    ---       (96,759 )

Total adjustments

    (93,426 )     (131,687 )

Net cash used in operating activities

    (156,885 )     (283,797 )
                 

Cash flows from investing activities:

               

Capital expenditures

    ---       2,483  

Net cash (used in) investing activities

    ---       2,483  
                 

Cash flows from financing activities

               

Net cash provided by/(used in) financing activities

    ---       ---  
                 

Net (decrease)/increase in cash

    (156,885 )     (281,314 )
                 

Cash – Beginning of year

    460,570       584,999  
                 

Cash – End of year

  $ 303,684     $ 303,684  
                 

Supplemental disclosure of cash flow information

               

Interest expenses

    ---       ---  

Income taxes

    ---       1,100